Bone marrow-derived mesenchymal stem cells

被引:247
作者
Kemp, KC [1 ]
Hows, J [1 ]
Donaldson, C [1 ]
机构
[1] Univ W England, Fac Sci Appl, Ctr Biomed Res, Bristol BS16 1QY, Avon, England
关键词
mesenchymal stem cell; differentiation; plasticity; hemopoietic stem cell transplantation; immunomodulation; gene transfer;
D O I
10.1080/10428190500215076
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Human mesenchymal stem cells (MSCs) contribute to the regeneration of mesenchymal tissues, and are essential in providing support for the growth and differentiation of primitive hemopoietic cells within the bone marrow micro-environment. Techniques are now available to isolate human MSCs and manipulate their expansion in vitro under defined culture conditions without change of phenotype or loss of function. Mesenchymal stem cells have generated a great deal of interest in many clinical settings, including that of regenerative medicine, immune modulation and tissue engineering. Studies have already demonstrated the feasibility of transplanted MSCs providing crucial new cellular therapy. In this review, many aspects of the MSC will be discussed, with the main focus being on clinical studies that describe the potential of MSCs to treat patients with hematological malignancies who are undergoing chemotherapy and/or radiotherapy.
引用
收藏
页码:1531 / 1544
页数:14
相关论文
共 156 条
[71]
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Fitzpatrick, LA ;
Koo, WWK ;
Gordon, PL ;
Neel, M ;
Sussman, M ;
Orchard, P ;
Marx, JC ;
Pyeritz, RE ;
Brenner, MK .
NATURE MEDICINE, 1999, 5 (03) :309-313
[72]
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Gordon, PL ;
Koo, WWK ;
Fitzpatrick, LA ;
Neel, MD ;
McCarville, ME ;
Orchard, PJ ;
Pyeritz, RE ;
Brenner, MK .
BLOOD, 2001, 97 (05) :1227-1231
[73]
Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy [J].
Hou, Z ;
Nguyen, Q ;
Frenkel, B ;
Nilsson, SK ;
Milne, M ;
van Wijnen, AJ ;
Stein, JL ;
Quesenberry, P ;
Lian, JB ;
Stein, GS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7294-7299
[74]
Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells [J].
Hurwitz, DR ;
Kirchgesser, M ;
Merrill, W ;
Galanopoulos, T ;
McGrath, CA ;
Emami, S ;
Hansen, M ;
Cherington, V ;
Appel, JM ;
Bizinkauskas, CB ;
Brackmann, HH ;
Levine, PH ;
Greenberger, JS .
HUMAN GENE THERAPY, 1997, 8 (02) :137-156
[75]
Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO
[76]
2-I
[77]
Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells [J].
Javazon, EH ;
Colter, DC ;
Schwarz, EJ ;
Prockop, DJ .
STEM CELLS, 2001, 19 (03) :219-225
[78]
JIANG XX, 2005, IN PRESS BLOOD
[79]
KEATING A, 1982, NATURE, V298, P280, DOI 10.1038/298280a0
[80]
Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation [J].
Kim, DW ;
Chung, YJ ;
Kim, TG ;
Kim, YL ;
Oh, IH .
BLOOD, 2004, 103 (05) :1941-1948